The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

Completed

Conditions studied: Newly-diagnosed Cancers, Non-cancer Controls

In brief

This protocol is a prospective, case-control multi-center diagnostic study to assess the sensitivity and specificity of blood-based screening tests for the early detection of multiple cancers.

Key facts

Study ID
NCT05516927
Run by
Freenome Holdings Inc.
People needed
788
Starts
2022-09-06
Expected to finish
2024-05-02
Last updated by the study team
2024-11-06

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.